These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

504 related items for PubMed ID: 30798260

  • 21. Diagnostic Function of 3D Optical Coherence Tomography Images in Diagnosis of Vogt-Koyanagi-Harada Disease at Acute Uveitis Stage.
    Zhao GL, Li RZ, Pang YH, Wang XQ, Peng HJ, Wei JF, Zhou Z.
    Med Sci Monit; 2018 Feb 03; 24():687-697. PubMed ID: 29396390
    [Abstract] [Full Text] [Related]

  • 22. The outcomes of indocyanine green angiography monitored immunotherapy in Vogt-Koyanagi-Harada disease.
    Chee SP, Jap A.
    Br J Ophthalmol; 2013 Feb 03; 97(2):130-3. PubMed ID: 23212203
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Retinal functional changes measured by microperimetry after immunosuppressive therapy in patients with Vogt-Koyanagi-Harada disease.
    Abu El-Asrar AM, Al-Mezaine HS, Hemachandran S, Hariz R, Kangave D.
    Eur J Ophthalmol; 2012 Feb 03; 22(3):368-75. PubMed ID: 21928252
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Retinal pigment epithelial changes in chronic Vogt-Koyanagi-Harada disease: fundus autofluorescence and spectral domain-optical coherence tomography findings.
    Vasconcelos-Santos DV, Sohn EH, Sadda S, Rao NA.
    Retina; 2010 Jan 03; 30(1):33-41. PubMed ID: 20010321
    [Abstract] [Full Text] [Related]

  • 28. Quantitative evaluation of "sunset glow" fundus in Vogt-Koyanagi-Harada disease.
    Suzuki S.
    Jpn J Ophthalmol; 1999 Jan 03; 43(4):327-33. PubMed ID: 10482481
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Clinical Outcomes of Patients with Vogt-Koyanagi-Harada Disease Over 12 Years at a Tertiary Center.
    Arevalo JF, Lasave AF, Gupta V, Kozak I, Al Harbi MB, Al Rushood AA, Al Dhibi HA.
    Ocul Immunol Inflamm; 2016 Oct 03; 24(5):521-9. PubMed ID: 26399962
    [Abstract] [Full Text] [Related]

  • 31. The effect on choroidal changes of the route of systemic corticosteroids in acute Vogt-Koyanagi-Harada disease.
    Park UC, Cho IH, Lee EK, Yu HG.
    Graefes Arch Clin Exp Ophthalmol; 2017 Jun 03; 255(6):1203-1211. PubMed ID: 28382438
    [Abstract] [Full Text] [Related]

  • 32. Retinal oximetry.
    Hardarson SH.
    Acta Ophthalmol; 2013 Mar 03; 91 Thesis 2():1-47. PubMed ID: 23470088
    [Abstract] [Full Text] [Related]

  • 33. The spectrum of Vogt-Koyanagi-Harada disease in Iran.
    Hedayatfar A, Hosseini SM, Karimi N, Falavarjani KG, Badie N, Zameni M, Soheilian M.
    Int Ophthalmol; 2018 Apr 03; 38(2):443-449. PubMed ID: 28260142
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Vogt-Koyanagi-Harada disease in Hispanic patients.
    Sukavatcharin S, Tsai JH, Rao NA.
    Int Ophthalmol; 2007 Apr 03; 27(2-3):143-8. PubMed ID: 17380271
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Retinal Microcirculation Defects on OCTA Correlate with Active Inflammation and Vision in Vogt-Koyanagi-Harada Disease.
    Liang A, Zhao C, Jia S, Gao F, Han X, Pei M, Qu Y, Xiao J, Zhang M.
    Ocul Immunol Inflamm; 2021 Nov 17; 29(7-8):1417-1423. PubMed ID: 32407159
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 26.